39232-02-5

Basic information

• Product Name: 4-(2-bromoethyl)-1,2-dichlorobenzene
• Synonyms: 4-(2-bromoethyl)-1,2-dichlorobenzene;3,4-Dichlorophenethyl broMide;Benzene, 4-(2-bromoethyl)-1,2-dichloro-
• CAS NO: 39232-02-5
• Molecular Formula: C₈H₇BrCl₂
• Molecular Weight: 253.95
• Mol File: 39232-02-5.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-(2-bromoethyl)-1,2-dichlorobenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-bromoethyl)-1,2-dichlorobenzene(39232-02-5)
• EPA Substance Registry System: 4-(2-bromoethyl)-1,2-dichlorobenzene(39232-02-5)

Safety Data

• Hazardous Substances Data: 39232-02-5(Hazardous Substances Data)

Usage

Uses

Used in Chemical Manufacturing:
4-(2-bromoethyl)-1,2-dichlorobenzene is used as an intermediate in the production of various chemicals, such as dyes, pharmaceuticals, and pesticides. Its unique structure allows it to be a versatile building block in the synthesis of a wide range of compounds.
Used as a Solvent:
Due to its chemical properties, 4-(2-bromoethyl)-1,2-dichlorobenzene serves as a solvent in certain industrial processes. Its ability to dissolve certain substances makes it useful in applications where a solvent is required.
Used in Organic Synthesis:
4-(2-bromoethyl)-1,2-dichlorobenzene is also utilized as a reagent in organic synthesis. Its presence can facilitate or enhance the outcomes of various chemical reactions, contributing to the formation of desired products.
Used in Environmental and Health Precautions:
While 4-(2-bromoethyl)-1,2-dichlorobenzene has various applications, it is also known to have potential environmental and health hazards. It can be harmful if ingested, inhaled, or comes into contact with skin or eyes. Therefore, it is used as a reminder for the necessity of proper handling, storage, and safety measures to mitigate risks associated with this compound.

Upstream product

• 497-19-8 sodium carbonate 
• 35364-79-5 2-(3,4-dichlorophenyl)ethanol 

Downstream Products

• 129254-91-7 1-(3,4-dichlorophenyl)-3-(pyridin-4-yl)butane 
• 1398180-01-2 ethyl 2-diazo-4-(3,4-dichlorophenyl)butanoate 
• 178261-34-2 2-(Benzyl-tert-butoxycarbonyl-amino)-4-(3,4-dichloro-phenyl)-butyric acid ethyl ester 
• 178261-35-3 2-(Benzyl-tert-butoxycarbonyl-amino)-4-(3,4-dichloro-phenyl)-butyric acid 
• 178261-39-7 Ethyl 2-(benzylamino)-4-(3,4-dichlorophenyl)butanoate 
• 178261-38-6 Ethyl 4-(3,4-Dichlorophenyl)-2-oxobutanoate 

Relevant articles and documents

THERAPEUTIC COMPOUNDS AND METHODS TO TREAT INFECTION

Disclosed herein are compounds of formula I: or a salt thereof and compositions comprising a compound of formula I or a pharmaceutically acceptable salt thereof. Also disclosed herein are methods for treating or preventing a bacterial infection in an animal comprising administering to the animal a compound of formula I or a pharmaceutically acceptable salt thereof, alone or in combination with a bacterial efflux pump inhibitor.

Muscarinic receptor antagonists

Muscarinic receptor antagonists of formula (I), and their pharmaceutically acceptable salts, wherein Y is --CH 2 --, --(CH 2) 2 --, --CH 2 O--, --(CH 2) 2 O-- or --CH 2 S--; R is --CH or --CONH 2 ; and R 1 is a group of formula (a), where R 2 and R 3 are each independently H, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, --(CH 2) n OH, halo, trifluoromethyl, cyano, --(CH 2) n NR 4 R 5, --CO(C 1 -C 4 alkyl), --OCO(C 1 -C 4 alkyl), --CH(OH)(C 1 -C 4 alkyl), --C(OH)(C 1 -C 4 alkyl 2, --SO 2 NH 2, --(CH 2) n CONR 6 R 7 or --(CH 2) n COO(C 1 -C 4 alkyl); R 4 is H or C 1 -C 4 alkyl; R 5 is H, C 1 -C 4 alkyl or C 1 -C 4 alkysulphonyl; R 6 and R 7 are each independently H or C 1 -C 4 alkyl; and n is 0, 1 or 2. The compounds are particularly useful in treating irritable bowel syndrome.